Global Sterile Compounding Pharmacies Market
Healthcare Services

Top 5 Insights From The Sterile Compounding Pharmacies Market Report 2024

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Sterile Compounding Pharmacies Global Market Report 2024, the sterile compounding pharmacies market is expected to show promising growth in the forecast period.

The sterile compounding pharmacies market has witnessed robust growth in recent years, with projections indicating a continued upward trajectory. Factors such as patient safety concerns, personalized medicine, and advancements in healthcare technologies have been instrumental in driving this growth.

Current Market Landscape

  • Market size projected to reach $5.3 billion in 2024, with a CAGR of 6.4%.
  • Factors driving growth include personalized medicine, home infusion therapies, and support for rare diseases.
  • Market players focusing on innovation and adherence to stringent regulatory standards.

Future Growth Prospects

  • Expected growth to $6.7 billion by 2028, with a CAGR of 6.0%.
  • Factors such as rising chronic diseases, aging populations, and drug shortages contribute to growth.
  • Major trends include automation, regulatory compliance, and personalized medicine.

View More On The Sterile Compounding Pharmacies Market Report 2024 –

Demand for Personalized Medicine

  • Surge in demand for personalized medicine propelling market growth.
  • Sterile compounding pharmacies crucial in offering customized medications in a sterile environment.
  • Growing adoption of personalized medicines, with a significant portion of new drug approvals being personalized.

Key Players in the Market

  • Major companies include B. Braun SE, PharMerica Corporation, and Fagron Group BV.
  • Diverse range of companies offering innovative solutions in sterile compounding.

Robotic Automation in Compounding

  • Adoption of robotic automation gaining traction.
  • Example: Omnicell Inc.’s IVX Station offering safe and efficient compounding preparations.
  • Features include automated compounding process and advanced safety measures.

Strategic Acquisitions

  • Revelation Pharma Corp’s acquisition of Innovation Compounding Inc. expands its national network.
  • Reflects the industry’s consolidation and focus on expanding service offerings.

Market Segmentation

  • Segmented by product, therapeutic area, route of administration, and end-users.
  • Provides tailored solutions catering to diverse patient needs and conditions.

Regional Insights

  • North America dominates the market, with Asia-Pacific expected to witness rapid growth.
  • Regional dynamics shape market trends and adoption rates.


The sterile compounding pharmacies market presents significant opportunities for growth and innovation in the coming years. With an increasing focus on personalized medicine, automation, and regulatory compliance, the industry is poised for substantial expansion. Collaborations, strategic acquisitions, and technological advancements will continue to drive the market towards safer, more efficient, and patient-centric solutions. As healthcare needs evolve, sterile compounding pharmacies play a crucial role in meeting the demands of patients and healthcare providers worldwide.

Request A Sample Of The Global Sterile Compounding Pharmacies Market Report 2024: